Delayed
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
488
JPY
+0.62%
+0.41%
+2.52%
Astena Holdings Co., Ltd.'s Equity Buyback announced on July 13, 2022 has closed with 676,400 shares, representing 1.69% for ¥299.97 million.
The company closed its plan on September 16, 2022.
Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022.
22-09-21
CI
Astena Holdings Co., Ltd.'s Equity Buyback announced on July 13, 2022 has closed with 676,400 shares, representing 1.69% for ¥299.97 million.
22-09-15
CI
Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022.
22-09-01
CI
Astena Holdings Co., Ltd. announces an Equity Buyback for 900,000 shares, representing 2.25% for ¥300 million.
22-07-13
CI
Astena Holdings Co., Ltd. authorizes a Buyback Plan.
22-07-12
CI
Insider Trends: MediciNova Insider Reports Option Conversion Extending 90-Day Buying Trend
21-07-23
MT
Tokyo Electric Power Incorporated : Olympic torch relay stirs mixed emotions ahead of its Fukushima start
21-03-24
RE
Tokyo Electric Power Incorporated : Olympic torch relay stirs mixed emotions ahead of its Fukushima start
21-03-23
RE
Daio Paper : Subsidiaries to Sell Shares in Parent Company
21-03-11
MT
Iwaki : Attributable Profit Drops Over 8% in Fiscal Nine Months 2020
21-03-08
MT
Insider Trends: Insider at MediciNova Converts Options Amid 90-Day Selling Trend
21-03-03
MT
Iwaki & Co., Ltd. cancelled the acquisition of Spera Pharma, Inc. from Bushu Pharmaceuticals Ltd.
21-01-23
CI
Iwaki & Co., Ltd. announced that it has received ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm
20-12-15
CI
Iwaki & Co., Ltd. announced that it expects to receive ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm
20-11-29
CI
Iwaki & Co., Ltd. agreed to acquire Maruman H&B Co.,Ltd. from MAJESTY GOLF Co., Ltd for ¥1 billion.
20-11-18
CI
Iwaki & Co., Ltd. signed a share transfer agreement to acquire Spera Pharma, Inc. from Bushu Pharmaceuticals Ltd. for ¥6 billion.
20-01-26
CI
Maeda Pharmaceutical Industry Co., Ltd. announced that it expects to receive funding from Iwaki & Co., Ltd.
20-01-26
CI
TechnoEcho Co., Ltd. acquired a 30% stake in Astena Holdings Co., Ltd..
19-12-25
CI
Iwaki Co., Ltd. agreed to acquire remaining 30% stake in TechnoEcho Co., Ltd. from Noriyuki Yamanaka and Makoto Nagase, Directors of Iwaki for approximately ¥160 million.
19-12-12
CI
Asco Co., Ltd. agreed to acquire Hokuyaku Co., Ltd. and A?M?I Co., Ltd. from Iwaki & Co., Ltd..
19-07-30
CI
Dalton Investments Submits Shareholder Proposal to Iwaki
18-11-19
CI
Iwaki & Co., Ltd.(TSE:8095) added to S&P Global BMI Index
17-09-18
CI
Iwaki Co., Ltd. completed the acquisition of 70% stake in TechnoEcho Co., Ltd.
16-12-25
CI
Iwaki Co., Ltd. agreed to acquire 70% stake in TechnoEcho Co., Ltd..
16-12-14
CI
Tranche Update on Iwaki & Co., Ltd.'s Equity Buyback Plan announced on April 12, 2016.
16-04-26
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.
More about the company
1st Jan change
Capi.
+2.52% 123M +26.47% 661B +26.74% 566B -6.33% 352B +19.35% 332B +4.23% 283B +13.43% 231B +4.71% 200B -9.53% 195B -4.04% 145B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1